Glucagon-like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Naïve Patients with Type 2 Diabetes Mellitus: A Multinational Preference Study.
about
Cost analysis of leuprorelin acetate in Japanese prostate cancer patients: comparison between 6-month and 3-month depot formulations.Adherence to antihyperglycemic medications and glucagon-like peptide 1-receptor agonists in type 2 diabetes: clinical consequences and strategies for improvement.Reproducibility and Validity of a Questionnaire Measuring Treatment Burden on Patients with Type 2 Diabetes: Diabetic Treatment Burden Questionnaire (DTBQ).Up-Titration Strategy After DPP-4 Inhibitor-Based Oral Therapy for Type 2 Diabetes: A Randomized Controlled Trial Shifting to a Single-Dose GLP-1 Enhancer Versus Adding a Variable Basal Insulin Algorithm
P2860
Glucagon-like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Naïve Patients with Type 2 Diabetes Mellitus: A Multinational Preference Study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Glucagon-like Peptide-1 Recept ...... ultinational Preference Study.
@en
Glucagon-like Peptide-1 Recept ...... ultinational Preference Study.
@nl
type
label
Glucagon-like Peptide-1 Recept ...... ultinational Preference Study.
@en
Glucagon-like Peptide-1 Recept ...... ultinational Preference Study.
@nl
prefLabel
Glucagon-like Peptide-1 Recept ...... ultinational Preference Study.
@en
Glucagon-like Peptide-1 Recept ...... ultinational Preference Study.
@nl
P2093
P2860
P1433
P1476
Glucagon-like Peptide-1 Recept ...... ultinational Preference Study.
@en
P2093
Alka Shaunik
Beverly Romero
Cynthia Alvarez
Emuella Flood
Marie de la Cruz
Stephanie Chen
Susan Grandy
P2860
P2888
P304
P356
10.1007/S13300-017-0230-2
P577
2017-02-02T00:00:00Z